Back to Trades
Total Value
$0
Filing Date
Jul 9, 2026
1 transactions
Trade Summary
On Jul 9, 2026, DVONCH JEROME J, Chief Financial Officer, reported $0 of Sonoma Pharmaceuticals, Inc. (SNOA) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Sonoma Pharmaceuticals, Inc.
- Ticker Symbol
- SNOA
- CIK
- 0001367083
Insider Information
- Name
- DVONCH JEROME J
- Role
- Chief Financial Officer
- Location
- BOULDER, CO
Filing Details
- Filing Date
- Jul 9, 2026
- Transaction Date
- Jul 9, 2026
- Accession Number
- 0001683168-26-005419
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 9, 2026 | SNOA derivative | 10,000 | — | Grant/Award | — |
Want live alerts when DVONCH JEROME J trades again?
Download Insider Trades to track SNOA, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock.
- (F2)The RSUs on the third anniversary of the grant date, or upon change of control.
- (F3)The RSUs were awarded and granted to Mr. Dvonch for services performed.